BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 35073967)

  • 1. Assessing transparency and accountability of national action plans on antimicrobial resistance in 15 African countries.
    Harant A
    Antimicrob Resist Infect Control; 2022 Jan; 11(1):15. PubMed ID: 35073967
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The global governance of antimicrobial resistance: a cross-country study of alignment between the global action plan and national action plans.
    Munkholm L; Rubin O
    Global Health; 2020 Nov; 16(1):109. PubMed ID: 33176810
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antimicrobial resistance control efforts in Africa: a survey of the role of Civil Society Organisations.
    Fraser JL; Alimi YH; Varma JK; Muraya T; Kujinga T; Carter VK; Schultsz C; Del Rio Vilas VJ
    Glob Health Action; 2021 Jan; 14(1):1868055. PubMed ID: 33475046
    [No Abstract]   [Full Text] [Related]  

  • 4. Opportunities and challenges in antimicrobial resistance policy including animal production systems and humans across stakeholders in Argentina: a context and qualitative analysis.
    Allel K; Fernandez-Miyakawa M; Gaze W; Petroni A; Corso A; Luna F; Barcelona L; Boden L; Pitchforth E;
    BMJ Open; 2024 Jun; 14(6):e082156. PubMed ID: 38889938
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of the inclusion of vaccination as an intervention to reduce antimicrobial resistance in AMR national action plans: a global review.
    van Heuvel L; Caini S; Dückers MLA; Paget J
    Global Health; 2022 Oct; 18(1):85. PubMed ID: 36253789
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Measuring the global response to antimicrobial resistance, 2020-21: a systematic governance analysis of 114 countries.
    Patel J; Harant A; Fernandes G; Mwamelo AJ; Hein W; Dekker D; Sridhar D
    Lancet Infect Dis; 2023 Jun; 23(6):706-718. PubMed ID: 36657475
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Qualitative Study on the Design and Implementation of the National Action Plan on Antimicrobial Resistance in the Philippines.
    Lota MMM; Chua AQ; Azupardo K; Lumangaya C; Reyes KAV; Villanueva SYAM; Legido-Quigley H; Roxas EA
    Antibiotics (Basel); 2022 Jun; 11(6):. PubMed ID: 35740226
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An analysis of national action plans on antimicrobial resistance in Southeast Asia using a governance framework approach.
    Chua AQ; Verma M; Hsu LY; Legido-Quigley H
    Lancet Reg Health West Pac; 2021 Feb; 7():100084. PubMed ID: 34327414
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Governance and Implementation of the National Action Plan on Antimicrobial Resistance in Tanzania: A Qualitative Study.
    Frumence G; Mboera LEG; Sindato C; Katale BZ; Kimera S; Metta E; Durrance-Bagale A; Jung AS; Mshana SE; Clark TG; Rweyemamu M; Legido-Quigley H; Matee MIN
    Antibiotics (Basel); 2021 Mar; 10(3):. PubMed ID: 33803077
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparative assessment of action plans on antimicrobial resistance from OECD and G20 countries using natural language processing.
    Özçelik EA; Doucet C; Kang H; Levy N; Feldhaus I; Hashiguchi TCO; Lerouge A; Cecchini M
    Health Policy; 2022 Jun; 126(6):522-533. PubMed ID: 35379524
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fighting Antimicrobial Resistance: Development and Implementation of the Ghanaian National Action Plan (2017-2021).
    Hein W; Aglanu LM; Mensah-Sekyere M; Harant A; Brinkel J; Lamshöft M; Lorenz E; Eibach D; Amuasi J
    Antibiotics (Basel); 2022 May; 11(5):. PubMed ID: 35625257
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An insight into the implementation of the global action plan on antimicrobial resistance in the WHO African region: A roadmap for action.
    Iwu CD; Patrick SM
    Int J Antimicrob Agents; 2021 Oct; 58(4):106411. PubMed ID: 34371112
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Attention to the Tripartite's one health measures in national action plans on antimicrobial resistance.
    Munkholm L; Rubin O; Bækkeskov E; Humboldt-Dachroeden S
    J Public Health Policy; 2021 Jun; 42(2):236-248. PubMed ID: 33597731
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Implementation of the World Health Organization Global Antimicrobial Resistance Surveillance System in Uganda, 2015-2020: Mixed-Methods Study Using National Surveillance Data.
    Nabadda S; Kakooza F; Kiggundu R; Walwema R; Bazira J; Mayito J; Mugerwa I; Sekamatte M; Kambugu A; Lamorde M; Kajumbula H; Mwebasa H
    JMIR Public Health Surveill; 2021 Oct; 7(10):e29954. PubMed ID: 34673531
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A review of national action plans on antimicrobial resistance: strengths and weaknesses.
    Willemsen A; Reid S; Assefa Y
    Antimicrob Resist Infect Control; 2022 Jun; 11(1):90. PubMed ID: 35739564
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Monitoring progress on Antimicrobial Resistance (AMR) response in the World Health Organization African region: Insights from the Tracking AMR Country Self-Assessment Survey (TrACSS) 2021 results for the human health sector.
    Gahimbare L; Mwamelo AJ; Yahya AA; Fuller W; Padiyara P; Prakash P; Balachandran A; Makubalo EL
    J Public Health Afr; 2023 Nov; 14(11):2392. PubMed ID: 38500695
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Articulating citizen participation in national anti-microbial resistance plans: a comparison of European countries.
    Castro-Sánchez E; Iwami M; Ahmad R; Atun R; Holmes AH
    Eur J Public Health; 2018 Oct; 28(5):928-934. PubMed ID: 29982459
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An analysis of existing national action plans for antimicrobial resistance-gaps and opportunities in strategies optimising antibiotic use in human populations.
    Charani E; Mendelson M; Pallett SJC; Ahmad R; Mpundu M; Mbamalu O; Bonaconsa C; Nampoothiri V; Singh S; Peiffer-Smadja N; Anton-Vazquez V; Moore LSP; Schouten J; Kostyanev T; Vlahović-Palčevski V; Kofteridis D; Corrêa JS; Holmes AH
    Lancet Glob Health; 2023 Mar; 11(3):e466-e474. PubMed ID: 36739875
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A governance framework for development and assessment of national action plans on antimicrobial resistance.
    Anderson M; Schulze K; Cassini A; Plachouras D; Mossialos E
    Lancet Infect Dis; 2019 Nov; 19(11):e371-e384. PubMed ID: 31588040
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.